Comparison ARS Pharmaceuticals (SPRY) with Competitors
ARS Pharmaceuticals (SPRY) industry is Biotechnology.
Profit Margin
SPRY-200.00%
Industry-0.13%
Upside-199.87%
Operating Margin
SPRY-265.20%
Industry-2073.25%
Upside+1808.05%
Debt-to-Equity
SPRY157.44%
Industry29.76%
Upside+429.04%
Free Cash Flow Yield
SPRY-20.77%
Industry-1.94%
Upside-18.83%
P/E
SPRY-4.25
Industry-18.88
Upside+1462.60%
P/S
SPRY9.10
Industry9.28
Upside-1.96%
P/B
SPRY15.22
Industry4.70
Upside+224.00%